The NRF2 inducer 4-Octyl itaconate inhibited pro-inflammatory cytokines (IL-6, IL-1b, TNFα) in PBMC of SLE patients (Tang et al. 2018). This evidence concerns the gene NFE2L2 and systemic lupus erythematosus.